Second act house (3 Ergebnisse)

Zustand: New.

Buch. Zustand: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - A DEEPER UNDERSTANDING. A BRIGHTER TOMORROW.Psilocybin is at the center of a scientific, medical, and cultural renaissance. Once dismissed and criminalized, it is now being carefully reexamined for its potential to help with treatment-resistant depression, anxiety, trauma, addiction, and end-of-life distress. But the story is more complex than headlines suggest.In Psilocybin: What We Know, What We Don't, and What We Lost Along the Way, Ed Chonko brings together the latest research, personal experiences, and real-world stories to explore what psilocybin can and cannot do. Drawing on science, history, policy, and lived experience, this book looks beyond the hype to examine the opportunities, risks, and bigger questions facing this remarkable substance-and what it means for mental health, meaning, and the human experience.Inside, you'll find:The history and rediscovery of psilocybin across cultures and medicineCurrent research on mental health, including depression, anxiety, PTSD, addiction, and end-of-life careDosing research and what we know (and don't know) about safety and effectsLegal and regulatory developments in the U.S. and around the worldPotential benefits, risks, and who may be most likely to benefitPerspectives from science, medicine, policy, and lived experienceReflections on healing, meaning, and what it means to be human.…

Buch. Zustand: Neu. Psilocybin | What We Know, What We Don't, and What We Lost Along the Way | Ed Chonko | Buch | Englisch | 2026 | Second Act House | EAN 9798998382307 | Verantwortliche Person für die EU: Libri GmbH, Europaallee 1, 36244 Bad Hersfeld, gpsr[at]libri[dot]de | Anbieter: preigu Print on Demand.…